Investment Rating - The report maintains a positive outlook on the industry, suggesting a focus on high-quality stocks with stable growth and reasonable valuations, particularly in the context of the North Exchange [3][5]. Core Insights - The North Exchange 50 Index experienced a significant increase of 100.53% over the past year, indicating strong market performance compared to other indices [2][10]. - The report highlights the recent listing of Guangxin Technology, which specializes in high-pressure transformers and insulation materials, projecting a revenue of 578 million yuan and a net profit of 116 million yuan for 2024 [27][28]. - The report emphasizes the importance of focusing on companies with stable performance and growth potential, particularly in sectors such as power equipment, computing, and communication, which have shown strong performance recently [21][27]. Summary by Sections North Exchange Market Overview - As of June 27, 2025, the North Exchange A-share component stocks totaled 268, with an average market capitalization of 3.139 billion yuan. The North Exchange 50 Index rose by 6.84% during the week [10][15]. - The trading volume increased, with an average daily turnover of 34.049 billion yuan, up 18.09% from the previous week [24][25]. New Stock Updates - Guangxin Technology was listed on June 26, 2025, focusing on high-pressure and ultra-high-pressure transformer products, with a significant growth trajectory in revenue and profit from 2021 to 2024 [27][28]. - The report notes that one company, Aomeisen, passed the review this week, while another, Jinhua New Materials, is scheduled for review next week [33]. Key Companies and Earnings Forecast - The report identifies several key companies with their respective earnings per share (EPS) and price-to-earnings (PE) ratios, recommending "Buy" for Tongli Co. and Wuxin Tunnel Equipment, and "Hold" for Kaide Quartz and Hualing Co. [5][34]. - For instance, Tongli Co. is projected to have an EPS of 1.99 in 2025 with a PE ratio of 10.84, indicating strong investment potential [5].

近五日涨跌:1.56% 市盈率：15.95倍 证券代码：002028 证券简称：思源电气 公告编号：2025-025 思源电气股份有限公司2024年度权益分派实施公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 日召开的2024年度股东大会审议通过，原分配方案为：以公司现有总股本 778,156,782 股 为基数，每10股送红股0股，转增0股，派发现金5元（含税），共计送红股0股，转增0股， 派发现金 389,078,391.00 元（含税），剩余未分配利润结转以后年度，不送红股，不以资 本公积金转增股本。 上市公司规范运作指引》等规定，利润分配方案实施前公司总股本可能存在由于可转债转股、 股份回购、股权激励行权、再融资新增股份上市等原因而发生变化，将按照"现金分红总额 固定不变"的原则调整分配比例。即公司以确定总派发金额389,078,391.00 元（含税）固 定不变的前提下，披露按最新股本总额计算的分配比例，调整向全体股东每10股派发现金股 利的具体金额。 ×10= 4.998403 元（含税）。 一、股东大会审议通过利润分配方案情况 ...

Core Points - The company has adjusted the issuance price for the specific target A-share stock offering from 6.24 CNY per share to 6.17 CNY per share after the annual equity distribution [1][2][3] - The total amount of funds to be raised from the issuance has been revised from a maximum of 200 million CNY to 197,756,409.94 CNY [3] Group 1: Issuance Price and Quantity Adjustment - The adjusted issuance price is calculated by deducting the cash dividend of 0.07 CNY per share from the previous price of 6.24 CNY per share [2] - The number of shares to be issued remains unchanged despite the adjustment in the issuance price [3] Group 2: Equity Distribution Implementation - As of December 31, 2024, the total share capital of the company is 262,080,000 shares, with a cash dividend of 0.70 CNY per 10 shares distributed, totaling 18,345,600 CNY [2] - The equity distribution record date is set for May 26, 2025, and the ex-dividend date is May 27, 2025 [2]

关于 江苏神马电力股份有限公司 第一期、第二期、第三期限制性股票激励计划 回购注销部分限制性股票相关事项的 法律意见书 中国 深圳 福田区益田路6001号太平金融大厦11、12层 邮政编码：518038 电子邮件（E-mail）：info@sundiallawfirm.com 网站（Website）：www.sundiallawfirm.com 电话(Tel)：(0755)88265288 传真(Fax)：(0755)88265537 法律意见书 目 录 法律意见书 广东信达律师事务所 关于江苏神马电力股份有限公司 第一期、第二期、第三期限制性股票激励计划 回购注销部分限制性股票相关事项的 法律意见书 信达励字2025第 073 号 致：江苏神马电力股份有限公司 广东信达律师事务所（以下简称"信达"）接受贵公司的委托，担任贵公 司第一期限制性股票激励计划、第二期限制性股票激励计划、第三期限制性股 票激励计划的专项法律顾问。根据《中华人民共和国公司法》《中华人民共和 国证券法》《上市公司股权激励管理办法》《上海证券交易所上市公司自律监 管指南第 2 号——业务办理》等有关法律、法规及规范性文件和《江苏神马电 力 ...

Core Viewpoint - The company announced a cash dividend distribution plan for the year 2024, proposing a distribution of 1 yuan (before tax) for every 10 shares held [1] Summary by Relevant Sections - **Dividend Distribution** - The proposed cash dividend is set at 1 yuan per 10 shares, which is inclusive of tax [1] - **Record Date and Conversion Suspension** - The record date for the dividend distribution will be announced separately - From June 27, 2025, until the record date, the Baiyun Convertible Bonds will suspend conversion [1] - Conversion will resume on the first trading day after the record date [1] - **Eligibility for Dividend** - Holders of the convertible bonds wishing to enjoy the dividend distribution must convert their bonds into shares by June 26, 2025 (inclusive) [1]

Group 1 - Beixin Road and Bridge's application for issuing shares to specific targets has been approved by the Shenzhen Stock Exchange, pending approval from the China Securities Regulatory Commission [1] - Wangbian Electric's shareholders plan to reduce their holdings by a total of up to 2.99% of the company's shares, with specific reductions detailed for each shareholder [1] - Guotou Zhonglu is planning a major asset restructuring, leading to a suspension of its stock trading for up to 10 trading days [2] Group 2 - Baiotai has signed a licensing agreement with SteinCares for the commercialization of BAT2406 in Brazil and Latin America, with total payments potentially reaching up to $10 million [3] - Dongfang Bio has obtained two medical device registration certificates for its products, which are valid until June 1, 2030 [4] - Pulaike's subsidiary has received a new veterinary drug registration certificate [5] Group 3 - Wanyi Technology has signed an agreement to establish a joint laboratory with the Energy Research Institute, with a total research and development budget of 6 million yuan [6] - Yingboer plans to use up to 300 million yuan of idle funds for financial management [7] - Blue Biological has received two new veterinary drug registration certificates [8] Group 4 - Jinkai New Energy intends to inject up to 1.247 billion yuan into its wholly-owned subsidiary to enhance its operational capabilities [9] - China Pacific Insurance's assistant general manager's qualification has been approved [10] - Zhaoyan New Drug is reducing its registered capital and notifying creditors [11] Group 5 - Weili Medical plans to invest 37.5 million yuan in establishing a medical industry investment fund [12] - Hongbai New Materials has signed a deposit agreement for idle raised funds [13] - Tongyou Technology is applying for a credit limit of 10 million yuan from a bank [14] Group 6 - Warner Pharmaceutical's subsidiary has received approval for its magnesium sulfate raw material drug [15] - Fuda Co. plans to establish a wholly-owned subsidiary with a capital contribution of 475 million yuan [16] - Yabao Pharmaceutical has obtained a loan commitment letter for stock repurchase of up to 90 million yuan [17] Group 7 - Zhongyin Securities' chairman has resigned due to work adjustments [18] - Aili Home has terminated its share reduction plan ahead of schedule [19] - Samsung New Materials has appointed a new financial officer [20] Group 8 - Guobang Pharmaceutical's subsidiary has received EU GMP certification for its product [21] - Yipin Hong has received a drug registration certificate for its injection solution [22] - Wenzhou Hongfeng's subsidiary has obtained a utility model patent certificate [23] Group 9 - Cangge Mining plans to sign a financial service agreement with Zijin Mining Group [24] - Naipu Mining's application for convertible bonds has been accepted by the Shenzhen Stock Exchange [25] - Shenyang Machine Tool has completed its major asset restructuring [26] Group 10 - Xinlaifu plans to distribute a cash dividend of 5 yuan per 10 shares [27] - Jiashitang plans to distribute a cash dividend of 1.7 yuan per 10 shares [28] - Manbuer plans to distribute a cash dividend of 2.5 yuan per 10 shares [29] Group 11 - Guo Wang Yingda plans to distribute a cash dividend of 0.51 yuan per 10 shares [30] - Changsha Bank's shareholder plans to reduce holdings by up to 0.92% [31] - Hu Nong Commercial Bank plans to distribute a cash dividend of 1.93 yuan per 10 shares [32] Group 12 - Huaxiang Co. plans to distribute a cash dividend of 1.17 yuan per 10 shares [33]

Core Points - Jiangsu Huachen Transformer Co., Ltd. has completed the registration of changes in business and has obtained a new business license [1] - The company held its 17th meeting of the third board of directors on April 28, 2025, and approved the change of registered capital and business scope [1] - The new registered capital is RMB 164,435,000 [1] Business License Details - The new business license includes the following information: - Unified Social Credit Code: 9132031266639531XY - Company Name: Jiangsu Huachen Transformer Co., Ltd. - Legal Representative: Zhang Xiaojin - Type: Joint Stock Company (Listed) - Established Date: September 4, 2007 - Business Term: From September 4, 2007, to long-term [1] Business Scope - The company’s business scope includes: - Licensed projects: Technology import and export, import and export agency, power facility installation, repair, testing, special equipment inspection and testing, special equipment design, goods import and export, road freight transport (excluding hazardous goods), power generation, transmission, and supply [1] - General projects include: - Manufacturing of transformers, rectifiers, inductors, and various electrical equipment, as well as research and development in energy-efficient technologies and renewable energy systems [1]

Group 1 - The announcement details the transfer of state-owned shares from Shaanxi Baoguang Group Co., Ltd. to China Xidian Group Co., Ltd., which will result in Baoguang Group becoming the direct controlling shareholder of Baoguang Co. [1] - The transfer involves 99,060,484 shares, representing a significant portion of the company's equity [1]. - The company is currently in the process of completing the necessary regulatory procedures and has already registered the property rights in the State-owned Assets Supervision and Administration Commission's system [2]. Group 2 - The company will continue to monitor the progress of the share transfer and will fulfill its information disclosure obligations in accordance with relevant laws and regulations [2]. - As of the date of the announcement, the share transfer is still in progress, and the company has not yet completed the transfer procedures [2].

证券代码：600312 证券简称：平高电气 公告编号：2025-020 河南平高电气股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 每股分配比例 A 股每股现金红利0.067元 ? 相关日期 | 股份类别 | 股权登记日 | | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- | --- | | Ａ股 | 2025/6/25 | － | 2025/6/26 | 2025/6/26 | | 四、 分配实施办法 （1）无限售条件流通股的红利委托中国结算上海分公司通过其资金清算系统向股权登记 日上海证券交易所收市后登记在册并在上海证券交易所各会员办理了指定交易的股东派发。 已办理指定交易的投资者可于红利发放日在其指定的证券营业部领取现金红利，未办理指定 交易的股东红利暂由中国结算上海分公司保管，待办理指定交易后再进行派发。 （2）派送红股或转增股本的，由中国结算上海分公司根据股权登记日上海证券交易所收 市后登记在册股东持股数，按比例直 ...

Group 1 - Chengjian Development received a dividend of 7.1282 million yuan from Beijing Jingcheng Jiaye Property Co., Ltd., in which it holds a 33.47% stake [1] - Shengnuo Bio expects a net profit attributable to shareholders of 77.0275 million to 94.1448 million yuan for the first half of 2025, representing a year-on-year increase of 253.54% to 332.10% [1] - JKN2301 dry mixed suspension has been approved for clinical trials, targeting children with influenza [5][6] Group 2 - Jindawei obtained a patent for a method of purifying natto kinase, with a validity of twenty years [2] - CITIC Guoan plans to increase its stake in China Broadcasting Hunan Company to approximately 5.29% through a capital increase of 278 million yuan [2] - Ji Electric announced the resignation of its general manager, Niu Guojun, due to work changes [3] Group 3 - Xintian Green Energy successfully issued 1.5 billion yuan in green medium-term notes with a term of 3+N years and an interest rate of 2.05% [7] - Hengrun Co. plans to invest 1.2 billion yuan in a project to produce 2,000 sets of wind turbine gearbox components [9] - Pulaide received a government subsidy of 10 million yuan, accounting for 15.87% of its audited net profit for the last fiscal year [10] Group 4 - Boteng Co. passed the EU QP audit, receiving a compliance statement for its CDMO services [12] - Zhou Dasheng added 7 self-operated stores in May, with total investments ranging from 900,000 to 6.5 million yuan [13] - Wantai Bio initiated a Phase III clinical trial for its live attenuated varicella vaccine [15] Group 5 - Shanghai Pharmaceuticals received a drug registration certificate for Pregabalin capsules in Thailand [19] - Sanxing Medical's subsidiary is expected to win contracts worth approximately 143 million yuan from State Grid projects [21] - Jiangsu Huachen plans to issue 460 million yuan in convertible bonds [24] Group 6 - Jian Gong Repair won a soil pollution remediation project worth 32.76 million yuan [25] - Dize Pharmaceutical completed patient enrollment for a global Phase III clinical trial of its drug [26] - Del Co. received acceptance for its application to issue shares for asset acquisition and raise matching funds [27] Group 7 - Beijing Kerui won multiple power grid projects with a total value of approximately 154 million yuan [27] - Xie Chuang Data signed financing lease contracts totaling 498 million yuan with Su Yin Financial Leasing [28] - Meige Intelligent submitted an application for H-share listing on the Hong Kong Stock Exchange [29][31] Group 8 - Aikodi plans to repurchase shares worth 100 million to 200 million yuan for employee stock ownership plans [54] - Kong Kong Industrial intends to sell 80% of Tianyuan Construction to its controlling shareholder [55] - Youyou Green Energy proposed a cash dividend of 12 yuan per 10 shares, totaling 50.4 million yuan [55]